Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 03-2014 | 01-2014 | 12-2013 | 04-2013 | 01-2013 | |
| Sales | 6 | 0 | 0 | 0 | 0 |
| Gross Profit | 6 | N/A | N/A | 1,530 | N/A |
| Operating Expenses | 1,862 | 0 | 0 | 1,410 | 0 |
| Operating Income | -1,856 | N/A | N/A | -1,410 | N/A |
| Interest Expense | 80 | 0 | 0 | 0 | 0 |
| Other Income | -79 | 0 | 0 | -640 | 0 |
| Pre-tax Income | -2,015 | 0 | 0 | -2,050 | 0 |
| Net Income Continuous | -2,015 | N/A | N/A | -2,050 | N/A |
| Net Income | $-2,015 | $N/A | $N/A | $-2,050 | $N/A |
| EPS Basic Total Ops | -61.48 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -61.45 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -61.48 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -61.45 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,798 | $N/A | $N/A | $-1,390 | $N/A |